Replies to post #51479 on Blackout Media Corp (BKMP)

[Jim Bishop]

OT: Biovail hasn't quite failed yet.

TORONTO, March 23 (Reuters) - Biovail Corp. (BVF.TO: Quote, Profile, Research) (BVF.N: Quote, Profile, Research) fourth-quarter profit more than doubled and it boosted its outlook on Thursday, but its shares slipped from an earlier high as investors worried about the long-term viability of its top-selling anti-depressant, Wellbutrin XL.

Biovail, Canada's biggest publicly traded drugmaker, was up 53 Canadian cents, or 1.8 percent, at C$30.58 in mid-afternoon on the Toronto Stock Exchange, but well off the 52-week high of C$32.96 it touched earlier in the session.